Logo image of XPER

XPERI INC (XPER) Stock Fundamental Analysis

NYSE:XPER - New York Stock Exchange, Inc. - US98423J1016 - Common Stock - Currency: USD

8.85  -0.1 (-1.12%)

After market: 8.85 0 (0%)

Fundamental Rating

2

XPER gets a fundamental rating of 2 out of 10. The analysis compared the fundamentals against 284 industry peers in the Software industry. Both the profitability and financial health of XPER have multiple concerns. XPER has a valuation in line with the averages, but on the other hand it scores bad on growth.


Dividend Valuation Growth Profitability Health

Quickly go to:

1

1. Profitability

1.1 Basic Checks

In the past year XPER was profitable.
XPER had a negative operating cash flow in the past year.
XPER had negative earnings in each of the past 5 years.
The reported operating cash flow has been mixed in the past 5 years: XPER reported negative operating cash flow in multiple years.
XPER Yearly Net Income VS EBIT VS OCF VS FCFXPER Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 0 -200M -400M -600M

1.2 Ratios

The Return On Assets of XPER (-13.80%) is worse than 66.30% of its industry peers.
XPER has a Return On Equity of -22.53%. This is comparable to the rest of the industry: XPER outperforms 41.30% of its industry peers.
Industry RankSector Rank
ROA -13.8%
ROE -22.53%
ROIC N/A
ROA(3y)-45.79%
ROA(5y)-31.11%
ROE(3y)-71.46%
ROE(5y)-48.38%
ROIC(3y)N/A
ROIC(5y)N/A
XPER Yearly ROA, ROE, ROICXPER Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 0 -50 -100 -150

1.3 Margins

With a decent Gross Margin value of 76.45%, XPER is doing good in the industry, outperforming 70.29% of the companies in the same industry.
XPER's Gross Margin has declined in the last couple of years.
XPER does not have Profit Margin and Operating Margin available, so we won't be analyzing them here.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM 76.45%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-0.88%
GM growth 5Y-4.4%
XPER Yearly Profit, Operating, Gross MarginsXPER Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 0 50 -50 -100 -150

More info and screens

2

2. Health

2.1 Basic Checks

XPER does not have a ROIC to compare to the WACC, probably because it is not profitable.
XPER has more shares outstanding than it did 1 year ago.
Compared to 5 years ago, XPER has less shares outstanding
Compared to 1 year ago, XPER has a worse debt to assets ratio.
XPER Yearly Shares OutstandingXPER Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 10M 20M 30M 40M 50M
XPER Yearly Total Debt VS Total AssetsXPER Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 200M 400M 600M 800M 1B

2.2 Solvency

Based on the Altman-Z score of -0.60, we must say that XPER is in the distress zone and has some risk of bankruptcy.
The Altman-Z score of XPER (-0.60) is worse than 74.64% of its industry peers.
A Debt/Equity ratio of 0.13 indicates that XPER is not too dependend on debt financing.
With a Debt to Equity ratio value of 0.13, XPER perfoms like the industry average, outperforming 48.91% of the companies in the same industry.
Industry RankSector Rank
Debt/Equity 0.13
Debt/FCF N/A
Altman-Z -0.6
ROIC/WACCN/A
WACC13.8%
XPER Yearly LT Debt VS Equity VS FCFXPER Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 0 200M 400M 600M 800M 1B

2.3 Liquidity

A Current Ratio of 1.29 indicates that XPER should not have too much problems paying its short term obligations.
XPER has a Current ratio of 1.29. This is in the lower half of the industry: XPER underperforms 60.51% of its industry peers.
A Quick Ratio of 1.27 indicates that XPER should not have too much problems paying its short term obligations.
XPER has a Quick ratio of 1.27. This is in the lower half of the industry: XPER underperforms 61.96% of its industry peers.
Industry RankSector Rank
Current Ratio 1.29
Quick Ratio 1.27
XPER Yearly Current Assets VS Current LiabilitesXPER Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 100M 200M 300M 400M

More info and screens

3

3. Growth

3.1 Past

XPER shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 1480.00%, which is quite impressive.
XPER shows a decrease in Revenue. In the last year, the revenue decreased by -2.12%.
Measured over the past years, XPER shows a small growth in Revenue. The Revenue has been growing by 5.12% on average per year.
EPS 1Y (TTM)1480%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%737.5%
Revenue 1Y (TTM)-2.12%
Revenue growth 3Y11.5%
Revenue growth 5Y5.12%
Sales Q2Q%1.92%

3.2 Future

The Earnings Per Share is expected to grow by 607.76% on average over the next years. This is a very strong growth
XPER is expected to show a decrease in Revenue. In the coming years, the Revenue will decrease by -2.35% yearly.
EPS Next Y4256.5%
EPS Next 2Y607.76%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next Year-5.5%
Revenue Next 2Y-2.35%
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

The Revenue growth rate is decreasing: in the next years the growth will be less than in the last years.
XPER Yearly Revenue VS EstimatesXPER Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 200M 400M 600M 800M
XPER Yearly EPS VS EstimatesXPER Yearly EPS VS EstimatesYearly EPS VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 1 2 3

More info and screens

6

4. Valuation

4.1 Price/Earnings Ratio

The Price/Earnings ratio is 12.83, which indicates a correct valuation of XPER.
Compared to the rest of the industry, the Price/Earnings ratio of XPER indicates a rather cheap valuation: XPER is cheaper than 89.49% of the companies listed in the same industry.
XPER is valuated cheaply when we compare the Price/Earnings ratio to 29.63, which is the current average of the S&P500 Index.
XPER is valuated reasonably with a Price/Forward Earnings ratio of 9.20.
94.93% of the companies in the same industry are more expensive than XPER, based on the Price/Forward Earnings ratio.
XPER is valuated cheaply when we compare the Price/Forward Earnings ratio to 22.68, which is the current average of the S&P500 Index.
Industry RankSector Rank
PE 12.83
Fwd PE 9.2
XPER Price Earnings VS Forward Price EarningsXPER Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 10 20 30 40 50

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A
XPER Per share dataXPER EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 2 4 6 8 10

4.3 Compensation for Growth

XPER's low PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.
XPER's earnings are expected to grow with 607.76% in the coming years. This may justify a more expensive valuation.
PEG (NY)0
PEG (5Y)N/A
EPS Next 2Y607.76%
EPS Next 3YN/A

More info and screens

0

5. Dividend

5.1 Amount

No dividends for XPER!.
Industry RankSector Rank
Dividend Yield N/A

More info and screens

XPERI INC

NYSE:XPER (2/21/2025, 8:04:00 PM)

After market: 8.85 0 (0%)

8.85

-0.1 (-1.12%)

Chartmill FA Rating
GICS SectorInformation Technology
GICS IndustryGroupSoftware & Services
GICS IndustrySoftware
Earnings (Last)11-06 2024-11-06/amc
Earnings (Next)02-26 2025-02-26/amc
Inst Owners91.55%
Inst Owner Change-0.66%
Ins Owners2.11%
Ins Owner Change0.42%
Market Cap396.75M
Analysts84
Price Target19.13 (116.16%)
Short Float %2.82%
Short Ratio3.64
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DP0%
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)318.96%
Min EPS beat(2)181.42%
Max EPS beat(2)456.51%
EPS beat(4)4
Avg EPS beat(4)203.21%
Min EPS beat(4)66.19%
Max EPS beat(4)456.51%
EPS beat(8)8
Avg EPS beat(8)137.68%
EPS beat(12)11
Avg EPS beat(12)98.3%
EPS beat(16)15
Avg EPS beat(16)82.13%
Revenue beat(2)0
Avg Revenue beat(2)-1.98%
Min Revenue beat(2)-3.63%
Max Revenue beat(2)-0.34%
Revenue beat(4)0
Avg Revenue beat(4)-3.1%
Min Revenue beat(4)-4.58%
Max Revenue beat(4)-0.34%
Revenue beat(8)1
Avg Revenue beat(8)-2.1%
Revenue beat(12)1
Avg Revenue beat(12)-13.61%
Revenue beat(16)1
Avg Revenue beat(16)-18.79%
PT rev (1m)0%
PT rev (3m)0%
EPS NQ rev (1m)0%
EPS NQ rev (3m)0%
EPS NY rev (1m)0%
EPS NY rev (3m)25.19%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)0%
Revenue NY rev (1m)0%
Revenue NY rev (3m)-0.86%
Valuation
Industry RankSector Rank
PE 12.83
Fwd PE 9.2
P/S 0.78
P/FCF N/A
P/OCF N/A
P/B 1.05
P/tB 1.95
EV/EBITDA N/A
EPS(TTM)0.69
EY7.8%
EPS(NY)0.96
Fwd EY10.87%
FCF(TTM)-1.16
FCFYN/A
OCF(TTM)-0.8
OCFYN/A
SpS11.34
BVpS8.42
TBVpS4.54
PEG (NY)0
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -13.8%
ROE -22.53%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM 76.45%
FCFM N/A
ROA(3y)-45.79%
ROA(5y)-31.11%
ROE(3y)-71.46%
ROE(5y)-48.38%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-0.88%
GM growth 5Y-4.4%
F-Score4
Asset Turnover0.83
Health
Industry RankSector Rank
Debt/Equity 0.13
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr 26.51%
Cap/Sales 3.14%
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 1.29
Quick Ratio 1.27
Altman-Z -0.6
F-Score4
WACC13.8%
ROIC/WACCN/A
Cap/Depr(3y)13.95%
Cap/Depr(5y)11.08%
Cap/Sales(3y)2.4%
Cap/Sales(5y)2.52%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)1480%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%737.5%
EPS Next Y4256.5%
EPS Next 2Y607.76%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)-2.12%
Revenue growth 3Y11.5%
Revenue growth 5Y5.12%
Sales Q2Q%1.92%
Revenue Next Year-5.5%
Revenue Next 2Y-2.35%
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y26.95%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year494.64%
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y-132.93%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y-73.3%
OCF growth 3YN/A
OCF growth 5Y-78.5%